ACHV
Achieve Life Sciences, Inc. [ACHV] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ACHV Stock Summary
Top ACHV Correlated Resources
ACHV
Top 10 Correlated ETFs
ACHV
Top 10 Correlated Stocks
ACHV
In the News
ACHV Financial details
Company Rating
-
Market Cap
148.82M
Income
-30.39M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-2.5
Forward P/E
-
PEG
0.41
P/S
-
P/B
22.24
P/C
-
P/FCF
-2.88
Quick Ratio
4.89
Current Ratio
5.36
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.56
EPS next Y
-
EPS next Q
-
EPS this Y
-62.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-23.53%
-
-
-
-
SMA20
-33.33%
SMA50
-33.33%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
-148%
ROE
-639%
ROC
-1.66%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.03-10.3
52W High
-80%
52W Low
-33.33%
RSI
33
Rel Volume
1.63
Avg Volume
99.22K
Volume
161.3K
Perf Week
-6.54%
Perf Month
-36.31%
Perf Quarter
-57.36%
Perf Half Y
-59.92%
-
-
-
-
Beta
1.279
-
-
Volatility
0.06%, 0.34%
Prev Close
-5.21%
Price
2
Change
-7.41%
Company Profile
- Volume Average 99.22K
- Market Capitalization 148.82M
- Employee 22
- CEO Mr. John A. Bencich M.B.A.
- Headquarters Vancouver,BC,CA
- IPO Date 1995-10-12
-
Website
https://www.achievelifesciences.com 
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
